학술논문
The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis
Document Type
Article
Author
Source
In: Mucosal Immunology . (Mucosal Immunology, 1 September 2018, 11(5):1454-1465)
Subject
Language
English
ISSN
19353456
19330219
19330219